3Jacobsen D W,gGatautis V J, Green R, et al. Rapid HPLC determination of total homocysteine and other thiol in serum and plasma: sex difference and correlation with cobalamin and folate concentration in health subjects[J]. Clin Chem, 1994, 40(5) :873-882.
4Ueland P M, Refsum H, Stabler S P, et al. Total homocycsteine in plasma of serum: Methods and applications [J]. Clin Chem, 1993,39(9) : 1764-1769.
5Selhub J,Jacques P F,Wilson P W, et al . Vitamin status and intake as primary determinants of homocysteinemia in an eiderly population. JAMA,1993,270(22) :2693-2698.
6Nygard O, Vollset S E, Refsum H, et al. total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study[J]. JAMA, 1995,274(19) : 1526-1533.
7Kanani P M,Sinkey C A,Browing R L, et al . Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans [ J]. Circulation, 1999, 100(11):1161-1168.
8Woo K S,Chook P, Lolin Y I, ez al. Hyperhomocysteinemia is a risk factors for arterial endothelial dysfunction in humans [J]. Circulation, 1997,96(8) : 2542-2544.
9Fryer R H,Wilson B D, Gubler D B, et al. Homoeysteine, arisk faetur for premature vaseular disease and thrombosis, induees tissue faetor aetivity in endothelial eells[J]. Arteroseler Thromb, 1993,13(9) : 1327-1333.
10Stamler J S, Osborne J A, Jaraki O, et al. Adrersa vascular effects of hornocysteine are modulated by endotheliurn-derived relaxing factor and related oxides of nitrogen [J]. J Chin Invest, 1993,91(1) :308-313.
1Bobinson K, Gupta A, Dennis V, et al.Hyperhomocusteinemia confers an independent increased risk of atherosolerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation, 1996, 94: 2743-2748.
2Hopkins PN,Wu LL, Hunt DC,et al. Lipoproitein (a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease. Arterioscler Thomb Vascu Biol, 1997,17: 2783-2792.
